1. LipidPlan in a box QI toolkit

LipidPlan in a box QI toolkit

General practitioners play an important role in the management of ASCVD. They are often the first point of contact for patients with non-acute cardiovascular disease, placing them in a key position to manage patients’ cholesterol.1,2

LipidPlan in a box: A quality improvement (QI) toolkit targeting LDL-C offers resources and tools to facilitate the use of Plan-Do-Study-Act (PDSA) cycles to improve ASCVD management in primary care. It is tailored to your practice’s needs, and aims to enhance outcomes for your patients living with ASCVD. It provides tools and resources to facilitate the use of PDSA cycles to test and implement improvements in the management of ASCVD with the aim of optimising outcomes for patients.

 

QI can benefit your practice, as well as your patients:

  • Continuous QI activities, in partnership with your local Primary Health Network (PHN), may be eligible for the Practice Incentives Program (PIP) QI Incentive3
  • QI activities, such as PDSA cycles, may contribute to fulfilling continuing professional development requirements4

 

LipidPlan in a box was developed with the guidance of a multidisciplinary steering committee of primary care experts.

LipidPlan in a box manual

The LipidPlan in a box manual contains everything you need to know to get started with ASCVD quality improvement activities in your practice.

Download

LipidPlan in a box PDSA cycle template

Download the PDSA cycle template to record your quality improvement activities.

Download

LipidPlan in a box resources

Access LipidPlan in a box clinical resources that can help you in implementing quality improvement activities for ASCVD in your clinical practice.

Show more

ASCVD, atherosclerotic cardiovascular disease; LDL-C, low-density lipoprotein cholesterol; PDSA, Plan-Do-Study-Act; QI, quality improvement.

References: 1. Carrington MJ et al. CODE RED: Overturning Australia’s cholesterol complacency. May 2020, Baker Heart and Diabetes Institute, Melbourne, Australia. 2. Audehm R. Characteristics and cholesterol treatment of patients with atherosclerotic cardiovascular disease (ASCVD), familial hypercholesterolaemia (FH), and those otherwise at moderate/high-risk of ASCVD in Australian primary care (SCOPE-GP) ID: 1695. Presented at Cardiac Society of Australia and New Zealand (CSANZ) congress, Adelaide, Australia, 1–4 August 2024. 3. Department of Health. Author. Practice Incentives Program Quality Improvement Incentive Guidelines Canberra: Australian Government Department of Health; 2019. Available at www1.health.gov.au/internet/main/publishing.nsf/Content/PIP-QI_Incentive_guidance (accessed October 2024). 4. The Royal Australian College of General Practitioners. Continuing Professional Development (CPD) Program: Handbook for general practitioners. East Melbourne, Vic: RACGP, 2020.

AU-27443. December 2024.
Print